Comparative transcriptome analysis of acne vulgaris, rosacea, and hidradenitis suppurativa supports high-dose dietary zinc as a therapeutic agent.
Li LiIrshad HajamJean S McGeeZhengkuan TangYe ZhangNikil BadeyEsther MintzerZhenrui ZhangGeorge Y LiuGeorge M ChurchYu WangPublished in: Experimental dermatology (2024)
Acne vulgaris, rosacea, and hidradenitis suppurativa are enduring inflammatory skin conditions that frequently manifest with akin clinical attributes, posing a considerable challenge for their distinctive diagnosis. While these conditions do exhibit certain resemblances, they also demonstrate distinct underlying pathophysiological mechanisms and treatment modalities. Delving into both the molecular parallels and disparities among these three disorders can yield invaluable insights for refined diagnostics, effective management, and targeted therapeutic interventions. In this report, we present a comparative analysis of transcriptomic data across these three diseases, elucidating differentially expressed genes and enriched pathways specific to each ailment, as well as those shared among them. Specifically, we identified multiple zinc-binding proteins (SERPINA1, S100A7, S100A8, S100A9 and KRT16) as consistently highly upregulated genes across all three diseases. Our hypothesis suggests that these proteins could bind and sequester zinc, potentially leading to localized zinc deficiency and heightened inflammation. We identified high-dose dietary zinc as a promising therapeutic approach and confirmed its effectiveness through validation in an acne mouse model.
Keyphrases
- hidradenitis suppurativa
- high dose
- oxide nanoparticles
- mouse model
- oxidative stress
- low dose
- genome wide
- systematic review
- randomized controlled trial
- stem cell transplantation
- physical activity
- healthcare
- rna seq
- drug delivery
- dna methylation
- cancer therapy
- genome wide identification
- electronic health record
- wound healing
- combination therapy
- affordable care act